FDA review of dupilumab for chronic spontaneous urticaria

Published Date: 13 Mar 2023

The FDA approval request for CSU is based on data from a pair of Phase 3 trials in two different populations.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Pomalidomide Reduces Severe Epistaxis in Hereditary Bleeding Disease.

2.

Adding Lenvatinib to Pembro Ups PFS in Head and Neck Cancer

3.

healthy despite having advanced cancer.

4.

Breast awareness: What to look for in your self-exam

5.

Significant differences in breast cancer care still exist, but surgeons can change.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot